Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

Overview of attention for article published in The Lancet, March 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news: 2 news outlets
blogs: 4 blogs
twitter: 13 X users

facebook: 2 Facebook pages
wikipedia: 1 Wikipedia page
f1000: 1 research highlight platform

Citations

dimensions_citation: 732 Dimensions

Readers on

mendeley: 281 Mendeley

Summary News Blogs X Facebook Wikipedia Research highlights Dimensions citations

So far, Altmetric has seen 3 reviews on 1 research highlight platform.

Recommended in Faculty Opinions

24 May 2013

This research output was recommended by a member of Faculty Opinions.

Recommended in Faculty Opinions

07 Mar 2013

This research output was recommended by a member of Faculty Opinions.

Recommended in Faculty Opinions

06 Mar 2013

This research output was recommended by a member of Faculty Opinions.

This page shows the most recent research highlights that mention this research output.

Click here to find out how to access more activity.